Human Reproduction, Vol. 14, No. 5, 1262-1265,
May 1999
© 1999 European Society of Human Reproduction and Embryology
Outcome of in-vitro fertilization through natural cycles in poor responders
Catholic University of Louvain, Faculty of Medicine, Department of Gynecology, St Luc's University Hospital, Avenue Hippocrate 10, 1200 Brussels, Belgium
This prospective study examines the benefits of using natural cycles instead of stimulated cycles in poor responders to in-vitro fertilization (IVF) treatment. Eleven patients in whom puncture was cancelled or who failed to conceive because of a poor response were included in the analysis. The data for natural cycles (n = 16) were compared with data obtained during previous stimulated cycles (n = 25) in the same women. Out of 16 natural cycles, 13 (81.3%) were scheduled for oocyte retrieval compared to 13 out of 25 stimulated cycles (52%). Eighteen metaphase II oocytes were obtained during stimulated cycles, giving a 66% fertilization rate. In natural cycles, 11 metaphase II oocytes were available giving a fertilization rate of 78.6%. A mean number of 51.5 ± 25 ampoules of gonadotrophins per cycle were used during ovarian stimulation. Three clinical pregnancies were obtained after embryo transfer in natural cycles (18.8%/started cycle) compared to none in stimulated cycles. Our findings demonstrate that an encouraging number of pregnancies can be achieved by IVF during natural cycles in poor responders to ovarian stimulation. This may not be the first approach to consider in IVF but it should be offered as an alternative after two ovarian response failures using classical protocols of stimulation.
Key words: IVF/natural cycles/poor responders
1 To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. M. Nelson, R. W. Yates, and R. Fleming Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy Hum. Reprod., September 1, 2007; 22(9): 2414 - 2421. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.J. Pelinck, N.E.A. Vogel, A. Hoek, E.G.J.M. Arts, A.H.M. Simons, and M.J. Heineman Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study Hum. Reprod., March 1, 2005; 20(3): 642 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kolibianakis, K. Zikopoulos, M. Camus, H. Tournaye, A. Van Steirteghem, and P. Devroey Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation Hum. Reprod., November 1, 2004; 19(11): 2545 - 2549. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.A. Akande, C.F. Fleming, L.P. Hunt, S.D. Keay, and J.M. Jenkins Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment Hum. Reprod., August 1, 2002; 17(8): 2003 - 2008. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.M.J. Janssens, C.B. Lambalk, R. Schats, and J. Schoemaker Successful in-vitro fertilization in a natural cycle after four previously failed attempts in stimulated cycles: Case report Hum. Reprod., October 1, 1999; 14(10): 2497 - 2498. [Abstract] [Full Text] [PDF] |
||||
